Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New mammal species enters human gene mutation equation in Germany:

This article was originally published in Clinica

Executive Summary

A lull in avian flu developments in Europe - since a spate of outbreaks in France recently put the EU on alert - has been broken by the discovery of the H5N1 virus in a new mammalian species in Germany. Although the infection of a stone marten has been attributed to contact with infected wild birds, the World Health Organization says it could indicate changes in the virus, which might facilitate human infection. "Further investigation is needed to determine whether evidence of H5N1 infection in new mammalian species has any significance for the risk of human infection or the potential of this virus to adapt to mammals, including humans," said the WHO.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT051113

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel